2011 annual financial data
Celldex Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -384.87%.
Operating income was -43,399,000 USD and net income was -44,799,000 USD.
Operating cash flow was -35,658,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,265,000 USD
- Operating income
- -43,399,000 USD
- Net income
- -44,799,000 USD
- Operating cash flow
- -35,658,000 USD